Biopharmaceutics Scientist/ Drug Product Design Biomodeler
Pfizer UK
During his dissertation research, Bart Hens (Pharm.D., Ph.D.) focused on the behavior of oral drug products in the human gastrointestinal tract (KU Leuven, Belgium). Based on the results of these studies, he started to use these data as a reference for optimization and validation of different in vitro and in silico models to increase their predictive power towards the in vivo outcome of an oral drug product (IMI-funded OrBiTo project). In January 2017, Bart started to work as a postdoctoral research fellow in the laboratory of Prof. Dr. Gordon L. Amidon, where they both explored the impact of gastrointestinal physiology on oral drug behavior by performing clinical aspiration studies. The gathered knowledge was used as a reference to develop a formulation predictive dissolution (fPD) test for oral drug products. This work was supported by the U.S. Food and Drug Administration (FDA). Since November 2020, Bart moved to Pfizer UK to work as a biopharmaceutics scientist and drug product design biomodeler under the supervision of Dr. Mark McAllister.
Disclosure information not submitted.
Tuesday, October 18, 2022
9:30 AM – 10:00 AM ET